Objectives: We describe 12 VIM-1-producing strains (7 Enterobacter cloacae, 2 Klebsiella pneumoniae and 3 clonal Klebsiella oxytoca strains) detected among clinically relevant Enterobacteriaceae isolates from routine cultures at the Hospital del Mar (Barcelona, Spain) from December 2006 to May 2007.
Introduction
Metallo-b-lactamases (MBLs), enzymes that confer resistance to carbapenems, belong to Ambler Class B. They are able to hydrolyse cephalosporins and penicillins but lack the ability to hydrolyse aztreonam. 1 MBLs are inhibited by chelant compounds such as EDTA. 1 The number of Enterobacteriaceae carrying MBLs in Europe has increased over the last few years, particularly in Klebsiella pneumoniae isolates. 2 Qnr determinants have been identified worldwide in Enterobacteriaceae as plasmid-mediated quinolone resistance mechanisms, together with the AAC(6 0 )-Ib-cr enzyme, a variant aminoglycoside acetyltransferase capable of inactivating fluoroquinolones. 3 These two resistance mechanisms are usually associated with extended-spectrum b-lactamases (ESBLs).
In this report we describe seven Enterobacter cloacae, two Klebsiella pneumoniae and three Klebsiella oxytoca MBL-producing strains. Moreover, as these strains showed decreased susceptibility to fluoroquinolones, the plasmidmediated genes implicated in this resistance were also studied [qnr and aac(6 0 )-Ib-cr genes]. 
Materials and methods

Bacterial strains and clinical data
Seventeen isolates among 2523 Enterobacteriaceae isolates were selected to determine the possible presence of carbapenemases. These isolates were obtained from routine cultures at the Hospital del Mar (Barcelona, Spain) from December 2006 to May 2007. One strain isolated from an endoscope was also included in this study.
Clinical and epidemiological data of patients infected and/or colonized with MBL-producing Enterobacteriaceae were collected from a review of clinical records in the hospital database.
Antibiotic susceptibility testing and phenotypic screening for detection of MBLs
Routine identification and susceptibility tests were performed by MicroScan system (Urine ComboS1 and NC36 panels) (Dade Behring, Sacramento, CA, USA). Isolates included in this study were those with an antibiotic profile compatible with MBL (susceptible to aztreonam but resistant to cephalosporins) and/or a reduced susceptibility to imipenem (.2 mg/L). Resistance to imipenem and ertapenem was confirmed by the disc diffusion method according to CLSI recommendations, 4 and confirmed by Etest (imipenem and imipenemþEDTA). The modified Hodge test 5 was used to detect carbapenemase activity. The disc diffusion susceptibility method was performed according to CLSI guidelines 4 using commercial discs (Bio-Rad, Marnes La Coquette, France) to determine resistance to other antimicrobial drugs, such as aminoglycosides, chloramphenicol, tetracycline, rifampicin, co-trimoxazole, trimethoprim, sulphonamides and quinolones.
PFGE
Clonal relationships between isolates were analysed by comparing PFGE profiles of genomic DNA digested with XbaI (GE Healthcare Bioscience). Electrophoresis was performed with a CHEF DRIII System (Bio-Rad, Richmond, CA, USA) using the following electrophoretic conditions for E. cloacae: linear pulse time ramp from 5 to 20 s and a run time of 6 h, followed by linear pulse time ramp from 25 to 40 s and a run time of 18 h. The conditions used for K. pneumoniae and K. oxytoca were a linear pulse time ramp from 10 to 25 s and a run time of 6 h, followed by a linear pulse time ramp from 25 to 45 s and a run time of 18 h. All electrophoretic gels were run at an angle of 1208 and a gradient of 6 V/cm.
Detection of b-lactamase, aac(6 0 )-Ib and qnr genes b-Lactamase genes were characterized by PCR and sequencing as previously described. 1, 6 The presence of aac(6 0 )-Ib and qnr genes was determined by PCR, using the primers described in the literature.
3 aac(6 0 )-Ib amplicons were later sequenced to identify the -cr variant.
Conjugation
Filter mating experiments were performed in solid medium with the 12 strains as donor strains, and with kanamycin and sodium azide-resistant Escherichia coli HB101 (lactose negative and plasmid free) as the recipient strain. VIM-and CTX-M-producing transconjugants were selected using Mueller-Hinton medium plates supplemented with 100 mg/L ampicillin, 4 mg/L cefotaxime and 13 mM sodium azide.
Plasmid analysis
The incompatibility groups of the MBL-and ESBL-carrying plasmids were determined by PCR-based replicon typing as previously described. 7 PFGE with S1 nuclease digestion of whole genomic DNA (S1-PFGE) was used to detect plasmids as previously decribed. 7 Gels were blotted and hybridized with specific probes for bla VIM-1 , bla CTX-M-9 and HI2, obtained by PCR amplification. DNA probes were labelled with digoxigenin (ECL TM Direct Nucleic Acid Labeling and Detection System).
Results and discussion
MBL-producing clinical isolates have been reported from various European countries 8 -12 and, in particular, MBL-and ESBLproducing strains seem to be emerging in Italy, 8 Greece, 9 Spain 10,11 and Turkey. 12 The VIM-1 and SHV ESBL association seems to be the most frequent to date. 8 -10 Among the 17 Enterobacteriaceae isolates suggestive of carrying a carbapenemase, we found 7 E. cloacae, 2 K. pneumoniae and 3 K. oxytoca that produced the VIM-1 enzyme. Three E. cloacae and three K. oxytoca strains were also CTX-M-9-producing strains, and one E. cloacae was also a CTX-M-3-producing strain (Table 1) . This is the first time that the VIM-1/CTX-M-9 or VIM-1/CTX-M-3 associations have been described. The only VIM enzyme associated with CTX-M ESBL has been described in a VIM-1-and CTX-M-15-producing K. pneumoniae strain from Turkey, 12 and in a VIM-1-and CTX-M-2-producing K. pneumoniae strain from Spain. 11 Four transconjugants were obtained in transfer experiments. One transconjugant was from E. cloacae 3 (EcloTC3), one from E. cloacae 7 (EcloTC7), one from K. pneumoniae 8 (KpneTC8) and one from K. oxytoca 10 (KoxyTC10). All four transconjugants produced only the VIM-1 enzyme and all were streptomycin, kanamycin, tobramycin and sulphonamide resistant. However, donor isolates were also resistant to tetracycline (seven strains) and to fluoroquinolones (six strains).
The plasmids carrying the bla VIM gene, of an unknown incompatibility group, had a size of 75 kb (eight strains) or 40 kb (three strains) and seemed to be associated with the aac(6 0 )-Ib-cr gene and with the qnrS gene ( Table 1) . aac(6 0 )-Ib-cr genes were found in all strains except one. Absence of hybridization with the aac(6 0 ) probe in K. pneumoniae 9 suggested that the aac(6 0 )-Ib-cr gene could be located in the chromosome. Finally, in one E. cloacae strain (E. cloacae 2), the bla VIM-1 gene was found in an HI2 plasmid of 290 kb together with the bla CTX-M-9 , qnrA, qnrS and aac(6 0 )-Ib-cr genes. Plasmids of a similar size were found in a study by Tato et al. 10 where the plasmids carrying the bla VIM-1 gene belonged to the IncI1 or HI2 group. In Greece, the VIM-1 enzyme was located in a transferable IncN plasmid. 9 The E. cloacae 3 strain was an exception; it was isolated from a colonoscope, and had the aac(6 0 )-Ib gene but not its variant. The qnrS gene seems to be the most prevalent gene in non-ESBL-producing E. cloacae strains, whereas the qnrB and qnrA genes are more frequently found in the suspected ESBL producers. 3 Our results are in concordance with these findings in that the E. cloacae and K. oxytoca CTX-M-9-producing strains had the qnrA gene. Nevertheless, the qnrS gene seemed to be related to the VIM-1 MBL as the donor strains and transconjugants obtained showed both qnrS and bla VIM-1 genes.
Four PFGE patterns were found among the E. cloacae isolates (seven or more different bands). The two VIM-1-producing K. pneumoniae isolates showed different PFGE patterns (seven or more different bands), whereas an identical PFGE pattern was found for the VIM-1-and CTX-M-9-producing K. oxytoca strains (Table 1 ). Contact transmission is the possible mechanism of acquisition in these patients with MBL-producing K. oxytoca infection. Clinical and epidemiological data were obtained from 11 patients (Tables 2 and 3 ). Six (54.5%) were women, mean (SD) age was 71.6 (15) years, and two out of three patients treated with carbapenems as empirical therapy had a favourable outcome. No temporal or geographical relationship was found among the patients. From a clinical point of view, infections due to MBL-producing Gram-negative bacilli generally affect seriously ill patients with severe underlying diseases after a prolonged hospital and/or intensive care unit stay. 9, 10 These characteristics were clearly present in our patients. Multidrug-susceptible P. mirabilis, K. pneumoniae and E. coli, and multidrug-resistant P. aeruginosa.
The plasmid and clonal diversity found supports the potential mobilization of this resistance determinant among plasmid scaffolds co-residing within the same cell, presumably by means of transposons, insertion sequences or recombination.
On behalf of the ESCMID study group for Antimicrobial Resistance Surveillance (ESGARS), Cornaglia et al. 13 discussed the lack of a satisfactory MBL surveillance system in Europe; they considered that this is due to lack of standardization in clinical laboratories and an overall limited awareness of the problem. More appropriate screening tests are needed to detect the low level of imipenem resistance. All of our 12 isolates were susceptible to carbapenems according to the MicroScan system. The disc diffusion method for both imipenem and ertapenem correctly identified five of the seven E. cloacae isolates as intermediate or resistant strains. The imipenem and imipenem-EDTA Etest strips showed a 'keyhole' in the middle of the MBL test strip, known as the phantom effect. The modified Hodge test was positive in all isolates.
In conclusion, all clinical laboratories should be aware of and able to detect carbapenem resistance. A gold standard method is needed for routine diagnostic and surveillance purposes. The increasing presence of isolates with acquired MBL associated with ESBLs should be emphasized. This is the first time that strains that produce both VIM-1 and CTX-M-9 or CTX-M-3 enzymes have been identified in Klebsiella and Enterobacter species. As the bla VIM-1 gene seems to be present in different plasmids and is associated with qnrS and aac-(6 0 )-Ib-cr genes, it is important to detect the plasmid and clonal diffusion of a strain within a hospital outbreak.
